0 ratings
JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ Paperback June 23, 2016
Genetic studies in the future we hope to be able to cure this disease is very dangerous.
JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ Paperback June 23, 2016
Item #: 47190560

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in

Item #: 47190560

USD 114

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from US

0 ratings Write a review
In stock
us Imported from USA store

QTY:

Order now and get it around Sunday, August 02
Our Top Logistics Partners
  • fedex
  • dhl
Genetic studies in the future we hope to be able to cure this disease is very dangerous.
U-Care Warranty:
None
Select a Plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified


paypal payment
visa payment
mastercard payment

What Stands Out

Targeted Research
Focuses on the JAK2-V617F mutation in patients with Polycythemia Vera in Iran, providing crucial insights for healthcare professionals addressing myeloproliferative disorders.
Cultural Context
Analyzes genetic mutations within the specific genetic and environmental context of Iranian patients, enhancing understanding of regional health challenges and improving tailored treatment options.
Clinical Relevance
Presents relevant findings that can directly inform clinical practices and assist in the development of targeted therapies, ultimately enhancing patient care and outcomes.

Product Details

Shop JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ Paperback June 23, 2016 online at a best price in Palau. 3659840106
Item Weight1 lbs (450 grams)

Who Should Buy?

Suitable For
  • Healthcare Professionals

    Doctors and researchers studying myeloproliferative disorders can gain valuable insights from this comprehensive evaluation.

  • Genetics Students

    Students specializing in genetics will find this book useful for understanding specific mutations and their implications for diseases.

  • Patients & Families

    Individuals affected by polycythemia vera may find the information beneficial for understanding their condition and potential treatments.

Not Suitable For
  • General Audience

    Individuals without a medical or scientific background may find the content too technical and difficult to understand.

Product Description

JAK2-V617F Mutation In Polycythemia Vera Of Iran: Evaluation of patients with myeloproliferative disorders Genetic mutation JAK2-V617F in polycythemia vera in the TABRIZ Paperback June 23, 2016

Have any Query? Chat with us

Customer Questions & Answers

  • Question: What is the JAK2-V617F mutation and its significance in polycythemia vera?

    Answer: The JAK2-V617F mutation is a genetic alteration commonly associated with polycythemia vera, a type of myeloproliferative disorder. This mutation leads to uncontrolled production of blood cells, which can increase the risk of blood clots and other cardiovascular complications. Understanding this mutation is crucial for diagnosis and treatment planning in patients with polycythemia vera, as it allows healthcare providers to tailor therapies based on the mutation's presence.
  • Question: Who is typically affected by polycythemia vera and the JAK2-V617F mutation?

    Answer: Polycythemia vera primarily affects adults, with the highest incidence in individuals aged 60 and older. However, it can occur in younger individuals as well. The JAK2-V617F mutation is found in approximately 95% of polycythemia vera cases, making it a reliable biomarker for diagnosis. Individuals with a family history of blood disorders or a previous history of blood clots may have a higher risk.
  • Question: How is the JAK2-V617F mutation tested?

    Answer: Testing for the JAK2-V617F mutation typically involves a blood sample analysis through polymerase chain reaction (PCR) techniques. This method allows for the detection of the specific genetic change in the JAK2 gene. The results help in confirming a diagnosis of polycythemia vera and can guide subsequent management and treatment decisions.
  • Question: What are the common symptoms of polycythemia vera related to the JAK2-V617F mutation?

    Answer: Individuals with polycythemia vera often experience symptoms such as headaches, dizziness, and blurred vision due to increased blood viscosity. Other symptoms may include fatigue, itching after a hot shower, and a ruddy complexion. Recognizing these symptoms is crucial for early intervention, which can help manage complications arising from the mutation.
  • Question: Can the JAK2-V617F mutation be inherited?

    Answer: The JAK2-V617F mutation is not directly inherited in a traditional sense, as it generally occurs sporadically during an individual’s lifetime. However, familial predispositions to myeloproliferative disorders may exist, indicating that genetic factors could play a role in risk. Understanding family medical history can aid in assessment and early detection of disorders associated with this mutation.
  • Question: What treatment options are available for patients with the JAK2-V617F mutation?

    Answer: Treatment options for patients with the JAK2-V617F mutation primarily focus on controlling symptoms and reducing the risk of complications. Common approaches include phlebotomy to reduce red blood cell mass, low-dose aspirin to mitigate thrombotic risks, and newer targeted therapies like JAK inhibitors. These treatments may help significantly reduce symptoms and improve the quality of life for affected patients.
  • Question: How does the JAK2-V617F mutation impact the prognosis of polycythemia vera?

    Answer: The presence of the JAK2-V617F mutation generally provides a clearer understanding of the disease and can influence prognosis. Patients with this mutation may respond better to certain targeted therapies, leading to improved management of the condition. Continuous monitoring and a personalized treatment approach can lead to a more favorable outcome, emphasizing the importance of early detection and regular follow-ups.
  • Question: What role does genetic counseling play for patients with the JAK2-V617F mutation?

    Answer: Genetic counseling is vital for patients with the JAK2-V617F mutation, offering support in understanding the implications of the mutation on health, family planning, and potential risks. It helps patients make informed decisions regarding their care and empowers them to take proactive steps in managing their health condition in collaboration with their healthcare providers.
  • Question: Where can I buy 'JAK2-V617F Mutation In Polycythemia Vera Of Palau: Evaluation of patients with myeloproliferative disorders' in Palau?

    Answer: You can purchase 'JAK2-V617F Mutation In Polycythemia Vera Of Palau: Evaluation of patients with myeloproliferative disorders' through Ubuy in Palau. Ubuy offers a convenient online shopping platform with access to various genetic research materials and books, ensuring that you can find the specific literature you're looking for with ease.

Genetics Editorial Review

No editorial reviews found

Customer Reviews & Ratings

5.0
1 customers ratings
  • 5 Star
    100%
  • 4 Star
    0%
  • 3 Star
    0%
  • 2 Star
    0%
  • 1 Star
    0%

Review this product

Share your thoughts with other customers

Platform Trust & Buyer Confidence

trustpilot logo
4.3/5 9200 + reviews
Read reviews
MA
Mohammad
Verified buyer

“Excellent quality and original too,when ubuy send original things I will appreciate that ,I very satisfied thank you”

23 July 2026 · via Trustpilot
CK
Chitra
Verified buyer

“The order and delivery progress was communicated very well. Package arrived within the estimated time. Products arrived as expected in good condition.”

22-Jul-26 · via Trustpilot
K
kund
Verified buyer

“Good supply of products. Safe payment methods, and shipment worldwide! Genuine products.”

23-Jul-26 · via Trustpilot
OO
Onesi
Verified buyer

“Was my first time buying a product from Ubuy, but I found it so helpful. This is reliable. Gonna place a new order!”

22 July 2026 · via Trustpilot
SJ
SAO JOHN
Verified buyer

“Ubuy is a great online platform to buy stuff. Reliable, fast delivery time and great value for money. I've been using Ubuy online shopping platform for three years now and will continue to do so.”

23 July 2026 · via Trustpilot
Secure Checkout Global Delivery Easy Returns Genuine Products

Product Price History

Important information

  • Limitations : For products shipped internationally, please note that any manufacturer warranty may not be valid; manufacturer service options may not be available; product manuals, instructions, and safety warnings may not be in destination country languages; the products (and accompanying materials) may not be designed in accordance with destination country standards, specifications, and labeling requirements; and the products may not conform to destination country voltage and other electrical standards (requiring use of an adapter or converter if appropriate). The recipient is responsible for assuring that the product can be lawfully imported to the destination country. When ordering from Ubuy or its affiliates, the recipient is the importer of record and must comply with all laws and regulations of the destination country.
  • Not all the products listed on Ubuy are for sale, as Ubuy is a global search engine. Products are subject to export/trade regulations.